sq-11725 has been researched along with Asthma, Bronchial in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bond, RA; Eikenburg, DC; Joshi, R; Kim, H; Knoll, BJ; Valdez, D | 1 |
| Bond, RA; Bouvier, M; Forkuo, GS; Joshi, R; Knoll, BJ; Leff, P; Parra, S; Thanawala, VJ; Valdez, DJ | 1 |
| Jabbal, S; Lipworth, B | 1 |
| Lipworth, BJ; Williamson, PA | 1 |
| Bond, RA; Dickey, BF; Franklin, AE; Garner, WJ; Hanania, NA; Lipworth, BJ; Mannava, B; Williamson, PA | 1 |
| Bond, RA; Knoll, BJ; Peng, H | 1 |
| Alfaro, VY; Bond, RA; Dickey, BF; Nguyen, LP; Okulate, AA; Singh, B; Tuvim, MJ | 1 |
| Abbott, A | 1 |
| Bond, RA; Dudekula, NB; Knoll, BJ; Lin, R; Nguyen, LP; Parra, S; Peng, H; Shardonofsky, F | 1 |
| Bond, RA; Dickey, BF; El-Wali, R; Flashner, M; Franklin, AE; Garner, WJ; Hanania, NA; O'Connor, BJ; Page, C; Parra, S; Ruoss, S; Shardonofsky, F; Singh, S | 1 |
| Ammar-Aouchiche, Z; Bond, RA; Clement, C; Dickey, BF; Ehre, C; Frieske, JM; Ho, SB; Kesimer, M; Knoll, BJ; Nguyen, LP; Omoluabi, O; Parra, S; Tuvim, MJ | 1 |
| Chupp, GL | 1 |
| Kerr, JH; Palazzo, MG; Raine, JM; Sleight, P | 1 |
| Evans, DY; Heaslip, RJ | 1 |
| Popa, V | 1 |
2 trial(s) available for sq-11725 and Asthma, Bronchial
| Article | Year |
|---|---|
The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study.
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nadolol; Pilot Projects; Prospective Studies; Respiratory Function Tests | 2008 |
Captopril-related (and -induced?) asthma.
Topics: Asthma; Captopril; Drug Combinations; Drug Therapy, Combination; Forced Expiratory Volume; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nadolol; Triamterene | 1987 |
13 other study(ies) available for sq-11725 and Asthma, Bronchial
| Article | Year |
|---|---|
Effects of β-blockers on house dust mite-driven murine models pre- and post-development of an asthma phenotype.
Topics: Adrenergic beta-Antagonists; Animals; Asthma; Carbazoles; Carvedilol; Disease Models, Animal; Inflammation; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nadolol; Ovalbumin; Phenotype; Phosphorylation; Propanolamines; Pyroglyphidae; Respiratory Hypersensitivity | 2017 |
β-Blockers have differential effects on the murine asthma phenotype.
Topics: Adrenergic beta-Antagonists; Allergens; Alprenolol; Animals; Asthma; Bronchoalveolar Lavage Fluid; Carbazoles; Carvedilol; Cell Count; Epinephrine; Female; Male; Mice, Knockout; Models, Biological; Mucins; Nadolol; Ovalbumin; Phenotype; Propanolamines; Propranolol | 2015 |
Of mice and men-the curious tale of β blockers in asthma.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Asthma; Bronchodilator Agents; Cyclic AMP; Down-Regulation; Drug Inverse Agonism; Humans; MAP Kinase Signaling System; Mice; Nadolol; Receptors, Adrenergic, beta-2; Up-Regulation | 2016 |
Beta blockers for asthma: a double-edged sword.
Topics: Adrenergic beta-Antagonists; Animals; Asthma; Contraindications; Disease Models, Animal; Humans; Nadolol | 2009 |
Response to salbutamol in patients with mild asthma treated with nadolol.
Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Asthma; Female; Humans; Male; Middle Aged; Nadolol; Propranolol; Respiratory Function Tests; Treatment Outcome | 2010 |
The effects of acute and chronic nadolol treatment on β2AR signaling in HEK293 cells.
Topics: Adrenergic beta-2 Receptor Antagonists; Asthma; Cell Culture Techniques; Cyclic AMP; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Immunoblotting; Ligands; Nadolol; Receptors, Adrenergic, beta-2; Signal Transduction; Transfection | 2011 |
Complementary anti-inflammatory effects of a β-blocker and a corticosteroid in an asthma model.
Topics: Adrenergic beta-2 Receptor Antagonists; Animals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Glucocorticoids; Leukocyte Count; Mice; Mice, Inbred BALB C; Mucins; Nadolol; Respiratory Mucosa | 2012 |
Beta-blocker goes on trial as asthma therapy.
Topics: Animals; Asthma; Clinical Trials as Topic; Contraindications; Humans; Nadolol; Propranolol; Time Factors; United States; United States Food and Drug Administration | 2004 |
Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model.
Topics: Adrenergic beta-Antagonists; Airway Resistance; Animals; Asthma; Blotting, Western; Bronchial Provocation Tests; Drug Administration Schedule; Fluorescent Antibody Technique; Intracellular Signaling Peptides and Proteins; Male; Methacholine Chloride; Metoprolol; Mice; Mice, Inbred BALB C; Nadolol; Ovalbumin; Propanolamines; Receptors, Adrenergic, beta-2 | 2008 |
Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Asthma; Disease Models, Animal; Female; Inflammation; Infusion Pumps; Injections, Intraperitoneal; Ligands; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mucins; Nadolol; Ovalbumin; Propanolamines; Specific Pathogen-Free Organisms | 2008 |
Say what, beta-blockers for asthma?
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Infusion Pumps; Injections, Intraperitoneal; Mice; Mucins; Nadolol; Ovalbumin; Propanolamines; Reproducibility of Results | 2008 |
Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane.
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Asthma; Bronchial Spasm; Female; Halothane; Humans; Nadolol; Propanolamines | 1981 |
Emetic, central nervous system, and pulmonary activities of rolipram in the dog.
Topics: Animals; Anxiety; Asthma; Brain; Bronchi; Dogs; Female; Heart Rate; Male; Nadolol; Pentobarbital; Phosphodiesterase Inhibitors; Pyrrolidinones; Respiration; Rolipram; Vomiting | 1995 |